ADME screen

The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.

NEW YORK (GenomeWeb News) – Agilent Technologies announced that it and a team of researchers from six organizations are developing models for toxicology testing with a $6 million grant from the National Institutes of Health.

RainDance is partnering with Roche 454 and Ambry in two separate alliances aimed at developing ADME gene screening panels for use on next-generation sequencing instruments.

The partners aim to develop a transporter-based assay system capable of predicting absorption, distribution, metabolism, and excretion of drug candidates.

The lawsuit claims that Invitrogen and CellzDirect are infringing a Celsis patent that relates to processes and methods for producing cryopreserved hepatocytes.

The Seoul-based life sciences firm will provide an array of services to help develop biological assays for cancer and endocrine disorders.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.